The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for Metastatic Breast Cancer
73 locations incl. Chandler
Sponsor: American Society of Clinical Oncology
Sex: All·Age: 65+
Code: NCT06377852·Phase 3·Recruiting·Listed Apr 2024
Clinical research site in Shelby, North Carolina · Atrium Health Levine Cancer Institute, 201 E Grover St, Shelby, NC 28150 · (980) 487-2600 · Website
Part of Levine Cancer Institute
As of July 2026, 1 paid clinical trial is recruiting at Levine Cancer Institute in Shelby, North Carolina. Active studies at this site focus on Metastatic Breast Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Shelby, NC · North Carolina clinical trials